Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
Conditions
- Adult Acute Lymphoblastic Leukemia
- Adult Acute Myeloid Leukemia
- Adult Diffuse Large B-Cell Lymphoma
- Adult Myelodysplastic Syndrome
- Adult Non-Hodgkin Lymphoma
- Aggressive Non-Hodgkin Lymphoma
- Childhood Acute Lymphoblastic Leukemia
- Childhood Acute Myeloid Leukemia
- Childhood Diffuse Large B-Cell Lymphoma
- Childhood Myelodysplastic Syndrome
- Childhood Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia in Remission
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Hematopoietic and Lymphoid Cell Neoplasm
- Mantle Cell Lymphoma
- Plasma Cell Myeloma
- Prolymphocytic Leukemia
- Recurrent Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- T-Cell Prolymphocytic Leukemia
- Waldenstrom Macroglobulinemia
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Hodgkin Lymphoma
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- DRUG: Cyclosporine
- DRUG: Fludarabine Phosphate
- OTHER: Laboratory Biomarker Analysis
- DRUG: Mycophenolate Mofetil
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- DRUG: Sirolimus
- RADIATION: Total-Body Irradiation
Sponsor
Fred Hutchinson Cancer Center
Collaborators